Ulta Beauty
ULTA Nasdaq Other Specialty Retail Financials FY2016βFY2025
Ulta Beauty's revenue rose 9.7% to $12.4 billion in fiscal 2025. Its operating margin was 12.4%, down from 13.8% a year earlier. Free cash flow was $1.1 billion, up 10.8%. It paid out $901 million in dividends and buybacks, 84% of free cash flow. The diluted share count fell 5.1%.
About these figures. Ulta Beauty has no long-term debt; its debt is the US$62 million it had drawn on its credit facilities at the end of fiscal 2025. Ulta Beauty held no short-term investments at the end of fiscal 2020 (its later filings show zero), so they count as zero that year.
What Ulta Beauty does
No business description yet.
- Legal name
- ULTA BEAUTY, INC.
- Fiscal year ends
- January 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001104659-26-035243
0001403568
Revenue and margins
Ulta Beauty had $12.4B of revenue in fiscal 2025, up 9.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 16.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1B in fiscal 2025, 8.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ulta Beauty returned $901M to shareholders in fiscal 2025, 84% of free cash flow. The diluted share count fell 5.1%.
Value Ulta Beauty yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $432M and divides by 45.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 22.8x Β· peers 21.2x Β· sector 17.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Ulta Beauty can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $432M | $738M | $767M | $703M | $494M |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $62.3M |
| Net debt / EBITDA | β0.3x | β0.4x | β0.4x | β0.4x | β0.2x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 608.6x | 766.4x | 504.4x | 376.3x | 158.5x |
| Current ratio | 1.5x | 1.6x | 1.7x | 1.7x | 1.4x |
| Quick ratio | 0.5x | 0.7x | 0.7x | 0.6x | 0.4x |
| Total assets | $4.8B | $5.4B | $5.7B | $6.0B | $7.0B |
| Total liabilities | $3.2B | $3.4B | $3.4B | $3.5B | $4.2B |
| Shareholders' equity | $1.5B | $2.0B | $2.3B | $2.5B | $2.8B |
| Net debt (β = net cash) | β$432M | β$738M | β$767M | β$703M | β$432M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$1.8M
3 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Kecia SteelmanPresident and CEO | Sold | 2,000 | $545.88 | $1.1M | Form 4 |
| Sep 11, 2026 | Lorna NaglerDirector | Sold | 600 | $537.31 | $0.3M | Form 4 |
| Jun 15, 2026 | George R Mrkonic JrDirector | Sold | 383 | $475.84 | $0.2M | Form 4 |
| Apr 7, 2026 | George R Mrkonic JrDirector | Sold | 452 | $539.29 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 4 / 9 | 6 / 9 |
| Accruals ratio | β3.3% | β2.4% | β5.4% |
| Altman Z'' | 4.76 | 4.66 | 3.84 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Ulta Beauty ULTA | $26.9B | 9.7% | 12.4% | 8.6% | 55.8% | 22.8x | 6 | |
| Chewy CHWY | $9.0B | 6.2% | 2.0% | 4.5% | β | 33.2x | 7 | Compare β |
| Tractor Supply TSCO | $17.5B | 4.3% | 9.5% | 4.8% | 28.5% | 17.4x | 6 | Compare β |
| Bath & Body Works BBWI | $4.2B | β0.2% | 15.4% | 11.9% | 47.5% | 5.5x | 5 | Compare β |
| Winmark WINA | $1.0B | 5.9% | 63.4% | 52.0% | β | 25.0x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.9B | $5.9B | $6.7B | $7.4B | $6.2B | $8.6B | $10.2B | $11.2B | $11.3B | $12.4B |
| Gross profit | $1.7B | $2.1B | $2.4B | $2.7B | $1.9B | $3.4B | $4.0B | $4.4B | $4.4B | $4.8B |
| Operating income | $655M | $785M | $854M | $901M | $237M | $1.3B | $1.6B | $1.7B | $1.6B | $1.5B |
| Interest expense | β | β | β | β | $7.0M | $2.1M | $2.1M | $3.3M | $4.2M | $9.7M |
| Pretax income | $656M | $787M | $859M | $906M | $231M | $1.3B | $1.6B | $1.7B | $1.6B | $1.5B |
| Income tax | $246M | $232M | $201M | $200M | $55.2M | $310M | $401M | $405M | $379M | $374M |
| Net income | $410M | $555M | $659M | $706M | $176M | $986M | $1.2B | $1.3B | $1.2B | $1.2B |
| Diluted EPS | $6.52 | $8.96 | $10.94 | $12.15 | $3.11 | $17.98 | $24.01 | $26.03 | $25.34 | $25.64 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $634M | $779M | $956M | $1.1B | $810M | $1.1B | $1.5B | $1.5B | $1.3B | $1.5B |
| Capital expenditure | $373M | $441M | $319M | $299M | $152M | $172M | $312M | $435M | $375M | $435M |
| Free cash flow | $261M | $339M | $637M | $803M | $658M | $887M | $1.2B | $1.0B | $964M | $1.1B |
| Depreciation and amortization | $210M | $253M | $280M | $296M | $298M | $269M | $241M | $244M | $267M | $301M |
| Stock-based compensation | $19.3M | $24.4M | $27.5M | $25.6M | $27.6M | $47.3M | $43.0M | $48.2M | $42.8M | $37.4M |
| Acquisitions | $0.0M | $0.0M | $13.6M | $0.0M | $1.2M | $0.0M | $0.0M | $0.0M | $0.0M | $387M |
| Share buybacks | $344M | $368M | $616M | $681M | $115M | $1.5B | $900M | $996M | $1.0B | $901M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $344M | $368M | $616M | $681M | $115M | $1.5B | $900M | $996M | $1.0B | $901M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $415M | $397M | $409M | $502M | $1.0B | $432M | $738M | $767M | $703M | $494M |
| Total debt | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $62.3M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $1.5B | $1.7B | $1.9B | $2.1B | $2.5B | $2.3B | $2.7B | $2.8B | $3.0B | $3.1B |
| Current liabilities | $529M | $642M | $824M | $1.1B | $1.3B | $1.6B | $1.7B | $1.7B | $1.8B | $2.2B |
| Inventory | $944M | $1.1B | $1.2B | $1.3B | $1.2B | $1.5B | $1.6B | $1.7B | $2.0B | $2.2B |
| Property and equipment, net | $1.0B | $1.2B | $1.2B | $1.2B | $996M | $915M | $1.0B | $1.2B | $1.2B | $1.4B |
| Total assets | $2.6B | $2.9B | $3.2B | $4.9B | $5.1B | $4.8B | $5.4B | $5.7B | $6.0B | $7.0B |
| Total liabilities | $1.0B | $1.1B | $1.4B | $3.0B | $3.1B | $3.2B | $3.4B | $3.4B | $3.5B | $4.2B |
| Shareholders' equity | $1.6B | $1.8B | $1.8B | $1.9B | $2.0B | $1.5B | $2.0B | $2.3B | $2.5B | $2.8B |
| Margins | ||||||||||
| Gross margin | 36.0% | 35.6% | 35.9% | 36.2% | 31.7% | 39.0% | 39.6% | 39.1% | 38.8% | 39.1% |
| Operating margin | 13.5% | 13.4% | 12.7% | 12.2% | 3.9% | 15.0% | 16.1% | 15.0% | 13.9% | 12.4% |
| EBITDA margin | 17.8% | 17.6% | 16.9% | 16.2% | 8.7% | 18.1% | 18.4% | 17.2% | 16.2% | 14.8% |
| Net margin | 8.4% | 9.4% | 9.8% | 9.5% | 2.9% | 11.4% | 12.2% | 11.5% | 10.6% | 9.3% |
| FCF margin | 5.4% | 5.8% | 9.5% | 10.9% | 10.7% | 10.3% | 11.5% | 9.3% | 8.5% | 8.6% |
| Returns | ||||||||||
| Return on capital | 38.9% | 44.1% | 47.0% | 50.0% | 15.3% | 96.0% | 106.5% | 93.4% | 72.2% | 55.8% |
| Return on capital employed | 34.0% | 36.6% | 36.9% | 29.6% | 6.3% | 37.3% | 47.5% | 43.4% | 37.8% | 34.1% |
| Return on equity | 27.4% | 33.4% | 36.6% | 37.9% | 9.0% | 55.8% | 71.1% | 60.9% | 50.4% | 43.6% |
| Return on assets | 17.1% | 20.3% | 21.6% | 17.5% | 3.5% | 20.0% | 24.5% | 23.3% | 20.5% | 17.7% |
| Growth | ||||||||||
| Revenue growth | 23.7% | 21.2% | 14.1% | 10.2% | β16.8% | 40.3% | 18.3% | 9.8% | 0.8% | 9.7% |
| Net income growth | 28.1% | 35.5% | 18.6% | 7.2% | β75.1% | 460.7% | 26.0% | 3.9% | β7.0% | β4.0% |
| EPS growth | 30.9% | 37.4% | 22.1% | 11.1% | β74.4% | 478.1% | 33.5% | 8.4% | β2.7% | 1.2% |
| FCF growth | 240.2% | 29.8% | 88.0% | 26.1% | β18.0% | 34.7% | 31.9% | β11.0% | β7.4% | 10.8% |
| Share count change | β2.2% | β1.4% | β2.9% | β3.5% | β2.7% | β3.0% | β5.7% | β4.1% | β4.4% | β5.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.5x | β0.4x | β0.4x | β0.4x | β2.0x | β0.3x | β0.4x | β0.4x | β0.4x | β0.2x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β | β | β | β | 33.9x | 608.6x | 766.4x | 504.4x | 376.3x | 158.5x |
| Current ratio | 2.9x | 2.6x | 2.3x | 1.8x | 1.9x | 1.5x | 1.6x | 1.7x | 1.7x | 1.4x |
| Quick ratio | 1.1x | 0.9x | 0.9x | 0.7x | 1.0x | 0.5x | 0.7x | 0.7x | 0.6x | 0.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.7% | 7.5% | 4.8% | 4.0% | 2.5% | 2.0% | 3.1% | 3.9% | 3.3% | 3.5% |
| Stock comp / revenue | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.6% | 0.4% | 0.4% | 0.4% | 0.3% |
| Payouts / FCF | 131.9% | 108.5% | 96.8% | 84.8% | 17.5% | 171.6% | 76.9% | 95.7% | 104.1% | 84.4% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 6.0 | 7.0 | 6.0 | 5.0 | 7.0 | 8.0 | 5.0 | 4.0 | 6.0 |
| Altman Z'' | 7.1 | 7.1 | 6.6 | 3.9 | 3.3 | 3.8 | 4.5 | 4.8 | 4.7 | 3.8 |
| Accruals ratio | β9.4% | β8.2% | β9.8% | β9.8% | β12.8% | β1.5% | β4.7% | β3.3% | β2.4% | β5.4% |
Source: SEC EDGAR XBRL filings (CIK 0001403568). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.